Type-A γ-aminobutyric (GABA A ) receptors are ligand-gated chloride channels with a very rich pharmacology. Some of their modulators, including benzodiazepines and general anaesthetics, are among the most successful drugs in clinical use and are common substances of abuse. Without reliable structural data, the mechanistic basis for the pharmacological modulation of GABA A receptors remains largely unknown. Here we report several high-resolution cryo-electron microscopy structures in which the full-length human α1β3γ2L GABA A receptor in lipid nanodiscs is bound to the channel-blocker picrotoxin, the competitive antagonist bicuculline, the agonist GABA (γ-aminobutyric acid), and the classical benzodiazepines alprazolam and diazepam. We describe the binding modes and mechanistic effects of these ligands, the closed and desensitized states of the GABA A receptor gating cycle, and the basis for allosteric coupling between the extracellular, agonist-binding region and the transmembrane, pore-forming region. This work provides a structural framework in which to integrate previous physiology and pharmacology research and a rational basis for the development of GABA A receptor modulators.
In vertebrates, GABA A receptors mediate both phasic and tonic neuronal inhibition in the adult central nervous system [1] [2] [3] . Their dysfunction leads to channelopathies associated with epilepsy, insomnia, anxiety and chronic pain 4 . GABA A receptors are among the most important human drug targets owing to their many allosteric sites, which bind compounds with anticonvulsant, anti-anxiety, analgesic, sedative and anaesthetic properties 5, 6 . Some of these-such as benzodiazepines (BZDs), which are typically positive allosteric modulators-entered clinical use decades before the identity of their receptors was known 7, 8 , and were crucial for the isolation 9 and subsequent cloning 10 of GABA A receptors. Other GABA A receptor ligands are important research tools, including the antagonists picrotoxin (PTX) and bicuculline (BCC) 5, 6 .
The binding modes and conformational effect of most GABA A receptor allosteric modulators are unknown. Docking attempts have had to rely on models based on the structures of homologous proteins, including the Caenorhabditis elegans glutamate-gated chloride channel α (GluCl) 11 , the Torpedo nicotinic acetylcholine receptor 12 or the human homopentameric β3 GABA A receptor 13 . Crystallographic and single-particle cryo-electron microscopy (cryo-EM) studies have revealed the interactions of GABA A -receptor-derived constructs with neurosteroids [14] [15] [16] , the agonist GABA [17] [18] [19] , and the BZD-site ligands bretazenil (BRZ) 20 and flumazenil (FLZ) 18, 20 . However, owing to the use of engineered receptors, some of which are structurally damaged by the presence of detergents, the interpretability of these models is limited.
Functional studies on small-molecule GABA A receptor modulators have also raised numerous questions. We will list here just a few examples. It is not known why the two agonist (GABA) binding sites, which should be structurally identical, are not functionally equivalent 21 . The mechanism of action of BZDs is also unclear, despite their widespread use as sedatives and anxiolytics. Moreover-unlike newer compounds such as bretazenil and flumazenil-classical BZDs including diazepam (DZP, also known by the trade name Valium) and alprazolam (ALP, also known by the trade name Xanax) act specifically through GABA A receptors containing α1, α2, α3 or α5, but not α4 or α6 subunit types 22, 23 . The basis for this specificity is not known. The plant alkaloid PTX, which is one of the most widely used GABA A receptor antagonists 24 , is thought to act as a channel blocker. However, its competitive antagonistic properties suggest that additional binding sites might exist 25, 26 . Another broadly used GABA A receptor antagonist, BCC, is thought to act competitively, although its preference for binding resting over desensitized receptors suggests that it might also act allosterically 27 . How reagents such as PTX and BCC actually bind, as well as how they work, is not yet known.
To address these questions, here we present five structures of the human synaptic α1β3γ2L GABA A receptor in complex with PTX, PTX and GABA (PTX/GABA), BCC, DZP and GABA (DZP/GABA), and ALP and GABA (ALP/GABA). We establish the binding modes and structural effect of these ligands and explain the molecular basis for their function. To obtain structures in which GABA A receptors can be observed in physiologically relevant conformations, we used a fulllength receptor variant from a thoroughly characterized cell line 28 and reconstituted it in a lipid bilayer 29 . Our results lay the foundation for understanding the fundamental principles of the action of small molecules on heteromeric synaptic GABA A receptors.
Picrotoxin and GABA binding modes
We first solved the structure of the α1β3γ2L receptor in complex with PTX (800 μM) to a nominal resolution of 3.1 Å ( Fig. 1a , Extended Data Fig. 1a -f, Extended Data Table 1 , Supplementary Video 1). PTX is an equimolar mix of two highly similar compounds, picrotin and picrotoxinin. Our structure illustrates picrotoxinin, which is known to be the more active compound, fully sequestered in the channel pore between the M2 2ʹ and 9ʹ rings ( Fig. 1b , c, Extended Data Fig. 1g , Supplementary Video 2). This agrees both with mutagenesis and electrophysiology Article reSeArcH results that implicate the 2ʹ, 6ʹ and 9′ M2 residues in PTX binding [30] [31] [32] , and with suggestions that PTX becomes 'trapped' in closed/resting channels of GABA A and Gly receptors upon agonist wash-off 33, 34 . The hydrophobic isoprenyl moiety is surrounded by the 9ʹ Leu ring, whereas the exocyclic oxygen atoms in the main PTX body form putative hydrogen bonds with the 6ʹ ring ( Fig. 1b, c) . In picrotin, the isoprenyl group is replaced by a polar tertiary alcohol; this is not compatible with 9′ Leu ring interactions, which explains why picrotin is less active.
We next determined a GABA A receptor structure in complex with PTX (800 μM) and the neurotransmitter GABA (5 μM) to a nominal resolution of 3.04 Å ( Fig. 2a , Extended Data Fig. 2a -c, Extended Data Table 1 , Supplementary Video 3). The orthosteric GABA-binding sites are located at the two β3 + /α1 − interfaces (the principal (+) and complementary (−) annotation of subunit faces is used here), capped by the extracellular loops-C of the β subunits 18, 19, 29 . Similar to the Torpedo nAChR α subunits 35 , in the agonist-free GABA A receptor the β3 loops-C adopt 'open' (outwards-projecting) conformations, whereas in the PTX/GABA-bound state they are 'closed' (Extended Data Fig. 2d ). Strong electron microscopy densities are present in the two orthosteric ligand-binding sites, enabling unambiguous modelling of GABA molecules in the 'aromatic boxes' formed by β3Tyr157, β3Phe200, β3Tyr205 and α1Phe65 ( Fig. 2b , Extended Data Fig. 2e , Supplementary Video 4). The GABA amino group engages in a cation-π interaction with β3Tyr205 and a network of hydrogen bonds 9′  L274, 9′  L264, 9′   T271, 6′   T256, 6′  T261, 6′ V257, 2′ S267, 2′
ig. 1 | Structure of the α1β3γ2L GABA A receptor in complex with picrotoxin. a, Cryo-EM map of the PTX-bound α1β3γ2L GABA A receptor viewed from the extracellular space (left) and parallel to the membrane plane (right). The PTX-binding site is boxed. b, c, Side-on (b) and top-down (c) views of PTX (carbon atoms in pink, oxygen atoms in red) bound to the channel pore, with the amino acid side chains lining the site shown as sticks. Dashed lines indicate hydrogen bonds.
Fig. 2 | Conformational impact of GABA binding to the α1β3γ2L
GABA A receptor. a, Cryo-EM map of the PTX/GABA-bound α1β3γ2L receptor viewed from the extracellular space (left) and parallel to the membrane plane (right). b, One GABA-binding pocket viewed from the extracellular space. GABA is shown in ball-and-stick representation with the atoms coloured as follows: carbon, khaki; oxygen, red; nitrogen, blue. c, Plot of the pore radii for the receptor bound to PTX (black dashed line) and PTX/GABA (green line). d, Superposition of ECDs from the PTX-bound (grey) and the PTX/GABA-bound (red/blue/yellow) receptor structures based on the global TMD alignment. Subunits were radially translated away by 10 Å from the pore axis to enable better visualization of conformational changes in the ECD upon GABA binding. GABA-induced ECD rotation is stated as the rotation angle around the ECD rotation axes, and the direction of motion is shown. e, f, Superposition of α1 ECDs from PTX-bound and PTX/GABA-bound structures reveals conformational changes induced by GABA binding in the orthosteric pockets at β3-B + / α1-A − (e) and β3-E + /α1-D − (f) interfaces. Dashed lines indicate hydrogen bonds, π-π stacking, π-cation interactions and salt bridges. 
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involving the β3Glu155 carboxyl, main-chain carbonyls of β3Ser156 and β3Tyr157, and the β3Tyr97 hydroxyl. The GABA carboxylate forms salt bridges with α1Arg67 and hydrogen bonds with α1Thr130 and β3Thr202 (Fig. 2b) . The GABA binding modes that we observe are generally consistent with those proposed in lower-resolution α1β1γ2 and α1β2γ2 GABA A receptor models 18, 19 ; however, there are some differences in the details, illustrated in the accompanying Letter 29 .
Allosteric cross-talk between PTX and GABA
Co-application of PTX (800 μM) with GABA (5 μM) and megabody 38 (Mb38; 2 μM; ref. 29 ) causes rapid and complete inhibition of whole-cell currents in HEK293 cells, with complete recovery after PTX washout (Extended Data Fig. 2f -h). Unexpectedly, in both PTX-bound and PTX/GABA-bound structures, the transmembrane domains (TMDs) adopt the same conformation-all five M2 helices present the hydrophobic 9′ Leu side chains towards the centre of the pore, constricting the pore radius to ~1.5 Å ( Fig. 2c , Extended Data Fig. 2i ). This suggests that PTX inhibition is not caused by blocking an open pore, but by inducing and maintaining a closed pore conformation. It is likely that, by stabilizing the closed/resting TMD state, PTX affects the conformation of the extracellular domain (ECD) and consequently modulates agonist binding. Indeed, PTX has been shown to reduce the apparent agonist affinity in GABA A receptors 26, 36 and to increase GABA dissociation 37 . Therefore, TMD closure by PTX constitutes the basis for allosteric communication between the PTX and GABA binding sites and explains how PTX appears to act as a competitive inhibitor 34, 38, 39 without binding to other receptor pockets. We conclude that the PTX-bound structure best illustrates the α1β3γ2L receptor in a closed/resting state (closed TMD, agonist-free ECD).
Mechanistic impact of GABA binding
Previous observations suggest that the two GABA-binding sites may not be functionally equivalent 21, 40 , and the β-E + /α-D − site has been estimated to have a threefold higher affinity for GABA than the β-B + /α-A − site 21 . By comparing ECDs in the PTX-bound and the PTX/GABA-bound structures, both of which have closed state TMDs, it is possible to visualize the initial conformational changes at the two agonist-binding sites upon the binding of GABA. Closure of β3 loops-C-likely to be the first step in the process-triggers remodelling of the β3-B + /α1-A − and the β3-E + /α1-D − interfaces, which leads to an anticlockwise (looking down the pore axis from the extracellular space) asymmetric rotation of all subunit ECDs (Fig. 2d ). This state is stabilized by new hydrogen-bond networks involving the β3Gly158, β3Tyr205 and α1Arg85 residues. The cation-π interaction between α1Arg85 and β3Tyr159 breaks, and the α1Arg85 side chain moves to the periphery of the interface ( Fig. 2e, f) . At the β3-B + /α1-A − interface, these changes enable the β3-B subunit to move closer to the α1-A subunit by 1.5 Å (as measured between β3Gly33C α and α1Pro80C α ), and the total buried surface between the two subunit ECDs increases by 184 Å 2 (Extended Data Fig. 2j , Extended Data Table 2 ). In the GABA-bound conformation, α1Phe15 and β3Phe31 residues form a hydrogen-π interaction and the side chains of α1Arg85 and β3Asp163 form new salt bridges, further interlocking the β3-E + /α1-D − ECD interface and increasing its total buried surface area by 234 Å 2 (Fig. 2f , Extended Data Table 2 , Supplementary Video 5).
The 'incomplete' closure of the β3-B + /α1-A − interface in the PTX/ GABA-bound structure, relative to the β3-E + /α1-D − interface, defines an intermediate conformation from which GABA can presumably dissociate more readily. Notably, in the desensitized (high affinity to GABA 41 ) receptor states-described later in this paper-both β3 + / α1 − interfaces close to the same extent. We conclude that the PTX/ GABA-bound structure represents a pre-active receptor state, in which agonist-induced conformational changes at the ECD level are not large enough to perturb the closed/resting TMD conformation 42 .
Mechanism of bicuculline antagonism
Being a highly efficient competitive antagonist, BCC was expected to induce a true GABA A receptor closed state 43 . We first verified whether BCC could close the α1β3γ2L receptor that had been prebound to Mb38. In whole-cell voltage-clamp experiments, application of a 42-s pulse of Mb38 produced currents ( Fig. 3a ) that were inhibited (102 ± 7%; n = 4) by the co-application of bicuculline (100 μM) ( Fig. 3b ) in a reversible fashion ( Fig. 3c ). We solved the cryo-EM structure of the α1β3γ2L heteromer in complex with Mb38 and BCC to a nominal resolution of 3.69 Å ( Fig. 3d , Extended Data Fig. 3a -c, Extended Data Table 1 ). Electron microscopy densities corresponding to BCC were observed at both of the orthosteric agonist sites (Extended Data Fig. 3d ), where the hydrophobic nature of the phthalide and isoquinoline rings of BCC enable its interaction with 'aromatic box' residues β3Tyr157, β3Phe200, β3Tyr205 and α1Phe65 ( Fig. 3e , Supplementary Video 6). Relative to the PTX-bound structure, the β3-B and β3-E subunit loops-C flex inward (by around 2.2 Å at the tip; Extended Data Fig. 3e ) in order to accommodate BCC, but they retain overall 'open' conformations (Extended Data Fig. 3f ). The channel pore of the BCC-bound α1β3γ2L receptor is fully closed by the M2 residues at three levels-9ʹ, 2ʹ and −2ʹ (Fig. 3f )-and its subunit conformations are almost identical to those of the PTX-bound structure (Extended Data Fig. 3e , f). The binding of BCC at the orthosteric sites prevents closure of the β3 + /α1 − subunit interfaces and rotation of the ECDs, and also stabilizes TMDs in the closed state, thus inactivating the channel. Table 1 , Supplementary Video 7). In both structures, GABA molecules are bound to the orthosteric agonist pockets and ALP or DZP occupy the canonical BZD-binding site at the α1 + / γ2 − interface, where they form extensive interactions ( Fig. 4d, e ). The densities of ALP and DZP were well defined, enabling us to distinguish the fused benzene-diazepine from the pendant phenyl rings (Extended Data Fig. 4g , h, Supplementary Video 8).
Benzodiazepine binding modes and mechanisms
The binding modes of ALP and DZP shown here are in agreement with the results of cysteine crosslinking experiments, in which isothiocyanate substitutions at the DZP C7 position reacted with cysteines introduced at the α1His102, α1Asn103 and γ2Asn60 positions, and isothiocyanate introduced at DZP C3 reacted with the α1Ser206Cys and α1Thr207Cys mutants 44 . The chlorine atoms at the C8 and C7 positions in ALP and DZP, respectively, interact with the α1His102 side chain. In the α4 and α6 subunits the equivalent positions are occupied by arginine residues, the larger side chains of which would sterically clash with ALP and DZP. This could explain why classical BZDs do not act on GABA A receptor subtypes containing α4 or α6 subunits 22, 45, 46 . The ALP-bound and DZP-bound structures also demonstrate that BZDs with a pendant phenyl ring do not share the binding mode reported for the benzodiazepine antagonist FLZ and the partial agonist BRZ 18, 20 (Extended Data Fig. 5a-e ). Compared with ALP and DZP, both FLZ and BRZ bind deeper into the BZD pocket and higher from the pocket floor, which is delineated by the side chain of γ2Asn60. This could be due to additional hydrogen bonds between the hydroxyl group of γ2Thr142 and either the imidazole nitrogen or the ester carbonyl of FLZ and BRZ 20 (Extended Data Fig. 5c, e ).
In the DZP/GABA-bound map, we also observed two strong densities at sites in the β3 + /α1 − TMD interfaces that are thought to be the binding sites of general anaesthethics 47 (Extended Data Fig. 4i , Supplementary Video 9). These densities are not present in the ALP/GABA-bound map and have a distinct shape that is attributable to DZP. In these pockets, the DZP A ring forms hydrophobic interactions with β3Met286 and β3Phe289 and the phenyl ring points towards α1Pro233 (Fig. 4f , Extended Data Fig. 4i ). Our structure corroborates previous electrophysiology and mutagenesis data, which suggests the existence of secondary DZP-binding sites that are responsible for the anaesthetic activity and biphasic GABA A receptor potentiation at higher DZP concentrations 40, 48 .
We next compared the α1 + /γ2 − interfaces in PTX-, PTX/GABA-, BCC-, ALP/GABA-and DZP/GABA-bound structures. Notably, the binding of ALP or DZP induced only minor rearrangements in the BZD pocket: γ2Asn60 adopted a different rotamer (Extended Data Fig. 5f ) and the tip of the α1 loop-C flexed outwards by around 0.6 Å (Extended Data Fig. 5f, g) . We therefore propose that BZDs such as ALP and DZP act as 'connectors' to stabilize the weakest ECD interface, α1-D + /γ2-C − (Extended Data Table 2), and facilitate the concerted ECD rotation upon GABA binding. Nanobody 38 (Nb38) and Mb38 might act similarly by 'crosslinking' the α1-A + /β3-E − and α1-D + / γ2-C − interfaces 20, 29 . FLZ antagonizes classical BZDs by competing for the same pocket; however, because it interacts largely with the α1-D + face 18, 20 , its binding would not confer the same inter-subunit connectivity benefits (Extended Data Fig. 5b, c) .
The channel-pore radii in the ALP/GABA-bound and the DZP/ GABA-bound structures are 2.6 Å and 2.3 Å, respectively, at the 9′ level, and are further constricted to 1.6 Å and 1.8 Å by the −2′ residues ( Fig. 4g ). Whole-cell voltage-clamp experiments indicate that a prolonged exposure to a combination of GABA (10 mM), Mb38 (2 μM) and diazepam (100 μM) leads to the complete desensitization of the α1β3γ2L receptor (Fig. 4h ). Subunit comparison between ALP/ GABA-bound and DZP/GABA-bound structures reveals that they adopt similar conformations (Extended Data Fig. 6 ); this illustrates a desensitized state of the receptor, in which it is bound to the agonist but the channel is closed only at the −2′ gate ( Supplementary Video 7) . 
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Allosteric interactions between ECDs and TMDs
To understand how the GABA-induced ECD rotation induces conformational changes in the TMD region, we compared ALP/GABA-bound and PTX-bound structures (Fig. 5a, b ). In the presence of ALP, GABA binding leads to equal closure of both β3 + /α1 − interfaces and a larger ECD rotation compared to the pre-open PTX/GABA-bound structure (Fig. 5a, Extended Data Figs. 2j, k, 7a, b, Supplementary Video 10) . This conformational change of the ECD triggers a clockwise rotation of the TMD. The resulting tilt of M2 helices moves the 9′ Leu side chains away from the channel pore and towards the inter-subunit interfaces (Fig. 5b , Extended Data Fig. 7c ). These motions are transmitted through interactions between the β1-β2 and the M2-M3 loops, whereas the β6-β7 (Cys) loops act as pivot points and the TMD bundles rotate as rigid bodies (Extended Data Figs. 7d, 8a-f, Supplementary Video 10).
The relative flexibility in the M2-M3 loops appears to regulate the efficiency of the ECD-TMD signal transduction. In α1 and γ2 subunits, the highly conserved arginine residues at the M2 19′ positions interact with and rigidify the M2-M3 loops. However, in β3 subunits, the strictly conserved Lys279 residues displace the 19′ Arg269 side chains, causing them to rotate and wedge in between the M1 and M2 helices of the neighbouring α1 subunits. This restricts the β3 TMD rotations (Extended Data Fig. 8g-l) , possibly dampening signal transduction. In α1 and γ2 subunits, positions equivalent to β3Lys279 are occupied by conserved threonine residues, which do not clash with 19′ Arg (Extended Data Fig. 8g-l) . The M2-M3 loops of β3 therefore seem to be more flexible than those of α1 and γ2 (Extended Data Fig. 7d , Supplementary Video 10). In agreement with these observations, α1β3γ2L receptors containing β3Lys279Thr mutations are 20-fold more sensitive to GABA relative to the wild-type receptors 49 .
We propose that GABA-induced signalling can be described by a 'lock-and-pull' mechanism. GABA binding triggers loops-C closure in β subunits, initiating rotation of their ECDs, which become 'locked' to the neighbouring α − interfaces. These conformational changes 'pull' the other ECDs, and transfer to the TMDs, leading to a concerted anticlockwise rotation. The inclusion of a BZD strengthens the α1 + /γ2 − ECD interface to facilitate these motions (Fig. 5c ). In β subunits, signal transduction to TMDs is modulated by the flexible M2-M3 loops, whereas the ECD rotations of α and γ subunits couple to the TMDs more efficiently because their M2-M3 loops are more rigid (Fig. 5d ).
Conclusion
The structures presented here illustrate how important pharmacological compounds, used broadly in research and in the clinic, interact with a full-length human heteromeric GABA A receptor to modulate its conformation and function. Picrotoxin must initially bind to an open channel pore and subsequently stabilizes a closed/resting receptor state, which explains its simultaneous channel blocker and allosteric antagonist activities. Bicuculline occupies the agonist-binding sites. However, unlike GABA, it cannot drive the rotation of β subunits and therefore stabilizes the closed channel pore. Comparison of agonist-free and GABA-bound structures delineates the molecular mechanism by which neurotransmitter binding to the β3 + /α1 − interfaces prompts a global rotation of ECD regions, initially in an asymmetrical fashion, and explains how different subunit types transduce this conformational change to their TMDs. We also characterize the binding sites of two major classical benzodiazepines-alprazolam and diazepam-and define their primary role as stabilizers of the α + /γ − interface, facilitating the concerted motion of GABA A receptor subunits. This work underlines the potential of cryo-EM to study the interactions of drugs with challenging yet highly valuable human membrane-protein targets 50 . Specifically, these structures might lead to the rational design of safer and more specific anxiolytic, sedative, hypnotic and anticonvulsant drugs.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-018-0832-5. Table 2 ). d, Differences in the relative orientations of ECD-TMD between the closed/resting and desensitized states illustrate how GABA binding and ECD rotation affect TMDs. Notably, the M2-M3 loops in β subunits deform more than the α and γ equivalents, resulting in lower degrees of M2 tilt and TMD rotation.
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Data reporting.
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. GABA A receptor production, purification and nanodisc reconstitution. Human tri-heteromeric α1β3γ2L was expressed in a stable, doxycycline-inducible HEK293S-TetR cell line 28 grown in suspension. The cell line was not authenticated or tested for mycoplasma contamination. The receptor comprised the full-length human α1 (UniProtKB P14867), β3 (P28472) and γ2L (P18507-2) subunits, each under individual antibiotic selection (zeocin, hygromycin-B, geneticin and blasticidin, respectively). For quality control and purification, a Flag tag (DYKDDDDK) 51 was fused to the α1 subunit N terminus and a rhodopsin-1D4 tag (TETSQVAPA) 52 was fused to the γ2L subunit C terminus, downstream of a (GGS) 3 GK spacer sequence. Cells were grown in FreeStyle 293 expression medium (Gibco) supplemented with 1% fetal bovine serum (Invitrogen), and antibiotics for selection (geneticin, hygromycin-B, zeocin and blasticidin, Thermo Fisher Scientific) at 37 °C, 160 r.p.m., 8% CO 2 . GABA A receptor expression was induced by the addition of doxycycline (2 μg ml −1 , Sigma) at a cell density of around 2 × 10 6 cells per ml. At the same time, the medium was supplemented with 5 mM sodium butyrate and the class I α-mannosidase inhibitor kifunensine (1 mg l −1 , Toronto Research Chemicals), in order to boost recombinant protein yields. Owing to this treatment, the majority of N-linked glycans were restricted to the immature, endoplasmic-reticulum-type Man 9 GlcNAc 2 . Cells were collected by centrifugation around 24 h after doxycycline addition. All steps of purification were performed at 4 °C or on ice. Cell pellets from 0.4 l of suspension culture were resuspended by brief vortexing in dilution buffer (50 mM HEPES pH 7.6, 300 mM NaCl) supplemented with 1% (v/v) mammalian protease inhibitor cocktail (Sigma-Aldrich). Membrane proteins were solubilized with 1% (w/v) n-dodecyl β-d-maltopyranoside (DDM, Anatrace; used for BCC-and DZP/GABA-bound samples) or lauryl maltose neopentyl glycol (LMNG, Anatrace; used for PTX-, PTX/GABA-, ALP/GABA-bound samples) with cholesterol hemisuccinate (CHS, Anatrace) at a 10:1 molar ratio, respectively, for 1 h. Insoluble material was removed by centrifugation (10,000g, 30 min). The α1β3γ2 GABA A receptors in the supernatant were captured on 1D4 affinity resin 13 (300 μl) while mixing slowly for 2 h. The beads were recovered by centrifugation (300g, 5 min) and washed with 100 ml of dilution buffer supplemented with 0.1% (w/v) DDM:CHS (10:1) or LMNG:CHS (10:1). To reduce the time α1β3γ2 GABA A receptor spends solubilized in detergent, and to streamline protein specimen preparation for cryo-EM, we reconstituted the α1β3γ2 heteromer into nanodiscs while it was bound to the 1D4 beads. Receptors were equilibrated with 1 ml of dilution buffer containing an excess (40 μl) of a phosphatidylcholine (POPC, Avanti) and bovine brain lipid (BBL) extract (type I, Folch fraction I, Sigma-Aldrich) mixture (POPC:BBL = 85:15) for 30 min. POPC and BBL extract stocks (10 and 20 mg ml −1 , respectively) were prepared by solubilization in 3% DDM. Beads were collected by centrifugation and an excess of MSP2N2 (0.6 mg ml −1 final concentration) was added together with Bio-Beads (40 mg ml −1 final concentration) and incubated for 2 h rotating gently. The MSP2N2 belt protein was produced as previously described 53 . After nanodisc reconstitution, the 1D4 resin and Bio-Bead mixture was washed extensively with dilution buffer to remove empty nanodiscs. For protein elution, 100 μl of mixture containing 1 part of dilution buffer and 3 parts of 2 mM 1D4 peptide stock (in MilliQ-grade H 2 O) was added onto the 1D4 resin for incubation overnight. The next day, beads were settled down by a short centrifugation (300g, 5 min) and the eluate was collected. Typically, the eluate contained 0.1-0.25 mg ml −1 of α1β3γ2 heteromer, which was then directly used for cryo-EM grid preparation. Mb38 production and purification. Megabodies (Mbs) are chimeric proteins comprising nanobodies (Nbs) fused to larger scaffold proteins (J.S., manuscript in preparation). A circular permutant of the extracellular adhesin domain of Helicobacter pylori (HopQ) 54 was inserted into the first β-turn connecting β-strands A and B of anti-α1 subunit Nb38 20 resulting in monomeric Mb Nb38 cHopQ (approximately 58 kDa). Mb Nb38 cHopQ was expressed as a C-terminally His6-and EPEA-tagged periplasmic protein in E. coli WK6 cells. Cell cultures were grown at 37 °C (120 r.p.m.) in Terrific Broth medium supplemented with ampicillin to an optical density of 0.8 at 600 nm followed by induction with 1 mM isopropyl β-d-1-thiogalactopyranoside and overnight expression at 28 °C (120 r.p.m.). Mb Nb38 cHopQ was extracted from periplasm by osmotic shock 55 , and further purified using nickel affinity chromatography and size-exclusion chromatography (Superdex 200 16/60 column, GE Healthcare) in 10 mM Tris pH 7.3, 140 mM NaCl at 21 °C. Purified Mb Nb38 cHopQ was concentrated to around 15 mg ml −1 , frozen in liquid nitrogen and stored at −80 °C. Cryo-EM sample preparation. α1β3γ2L heteromeric receptors reconstituted into nanodiscs were supplemented with small-molecule compounds at the concentrations indicated in the main text, and with Mb38 (1-2 μM) to improve particle alignment and the proportion of side views in cryo-EM images. In brief, 3.5 μl of sample was applied onto glow-discharged gold R1.2/1.3 300 mesh UltraAuFoil grids (Quantifoil) for 30 s and then blotted for 5.5 s before plunge-freezing the grids into liquid ethane cooled by liquid nitrogen. Plunge-freezing was performed using a Vitrobot Mark IV (Thermo Fisher Scientific) at approximately 100% humidity and 14.5 °C. Cryo-EM image collection and processing. Cryo-EM data were collected on a 300 kV Titan Krios microscopes (Thermo Fisher Scientific) fitted with a GIF-Quantum energy filter (Gatan) and Volta Phase Plate (Thermo Fisher Scientific). Micrographs were recorded in counting mode using K2 Summit (Gatan) or Falcon 3EC (Thermo Fisher Scientific) direct electron detectors. For sample-specific data collection parameters, see Extended Data Table 2 .
Datasets were analysed using the same basic processing pipeline in RELION 3.0 56 as described below. First, MotionCor2 57 and Gctf 58 wrappers in RELION 3.0 were used to motion-correct movies, and to estimate the contrast transfer function and phase shift parameters, respectively. Poor-quality images were discarded after manual inspection. For particle picking, a Gaussian blob was used as a template to auto-pick particles from a small set of micrographs and 2D classification was performed. Selected 2D classes were used as templates for auto-picking particles from all micrographs. Two rounds of reference-free 2D classifications were performed and well-aligned 2D classes showing clear GABA A receptor projections were selected for 3D reconstruction. An initial reference-free 3D model was generated in RELION 3.0 using stochastic gradient descent (SGD) methodology 59 . Selected particles were 3D-refined ('gold standard' refinement) and Bayesian polishing of particles was performed 60 . Next, the polished particles were classified into eight 3D volumes without particle alignment. Particles from volumes with the highest resolution were combined and 3D-refined using a soft mask and solvent-flattened Fourier shell correlations (FSCs). Beam tilt correction and per-particle contrast transfer function refinement implementations in RELION 3.0 were applied, resulting in further 0.1-0.2 Å increase in resolution. Notably, for the DZP/GABA-bound GABA A receptor dataset, beam tilt correction helped to increase the resolution from 3.82 Å to 3.58 Å. The resolution was estimated using relion_postprocess with the FSC criteria of 0.143. Local map resolution was estimated with MonoRes 61 .
The initial atomic model used in this work was obtained from the truncated α1β3γ2 heteromer structure 20 . First, ECDs and TMDs from this model were fit to the PTX/GABA-bound α1β3γ2 heteromer map (3.04 Å nominal resolution) as rigid bodies using UCSF Chimera 62 . Coot 63 was used to adjust the model and build the regions absent in the truncated receptor form. The model was then subjected to several rounds of global refinement and minimization in real space using phenix_real_space_refine 64 . The resulting model served as a starting point for the other structures, applying the same refinement strategy. The geometry constraint files for small-molecule ligands used in the refinement were generated using the Grade Web Server (Global Phasing). The quality assessment of geometry in all models was performed using the MolProbity 65 Web Server. For the refinement protocol validation, each final model coordinates were displaced by 0.5 Å and refined using phenix_real_space_refine against one of each half-map sets produced by RELION 3.0. FSC curves were then calculated between this model and the half-map used for refinement ('work') and the half-map, which was not used for refinement, ('free') using phenix.mtriage 66 . In addition, the refined models were also compared against the final sharpened map ('full'). For all structures, the separation between FSC work and FSC free curves was not significant, indicating that the models were not over-refined.
Subunit interface surface and associated free energy parameter analysis was performed using the PDBePISA server 67 . Pore diameters were calculated using the HOLE 68 plug-in in Coot. Structural figures were prepared using UCSF Chimera 62 . Global TMD alignments were performed using the align command in PyMol (Schrödinger). TMD boundaries for global alignments are as follows: α1 residues 233-309 and 392-418, β3 residues 218-302 and 419-447, γ2 residues 233-319 and 411-436. ECD alignments were performed using the match command in UCSF Chimera. ECD boundaries for structural alignments: α1 residues 9-222, β3 residues 8-217, γ2 residues 26-232. Root mean square deviations (r.m.s.d.) were calculated using the r.m.s.d. function in UCSF Chimera. M2-M3 loop boundaries for r.m.s.d. calculations are as follows: α1 residues 276-284, β3 residues 271-279, γ2 residues 286-294. Rotation angles were calculated using UCSF Chimera. Electrophysiology. HEK293S cells producing α1β3γ2L receptors 28 were grown on glass coverslips, and expression was induced with 0.1-2 μg ml −1 doxycycline for 14 to 28 h depending on the level of current required. For pulling outside-out macro-patches, we used poly-l-lysine-coated glass coverslips (Becton Dickinson). Cells were also treated with kifunensine (5 μg ml −1 ) at the time of induction.
Currents were recorded in either whole-cell or outside-out configuration of the patch clamp using an Axopatch 200A amplifier (Molecular Devices). Ligands were applied via a quad-channel super-perfusion pipette coupled to a piezoelectric element that switched the super-perfusion solution in <1 ms as described previously 69 . Data were acquired using Clampex 8.2 (Molecular Devices). For short drug applications, data were acquired at 10 kHz and filtered at 5 kHz, whereas for longer applications, data were collected at 2 kHz and filtered at 1 kHz. Cells or 1 nature research | reporting summary 
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